Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 83.85B | 80.26B | 85.75B | 72.30B | 55.95B |
Gross Profit | 31.87B | 27.71B | 27.15B | 24.69B | 19.22B |
EBITDA | 22.40B | 17.81B | 17.59B | 16.00B | 12.00B |
Net Income | 14.08B | 10.92B | 10.55B | 9.68B | 7.13B |
Balance Sheet | |||||
Total Assets | 130.59B | 118.17B | 107.27B | 101.19B | 85.11B |
Cash, Cash Equivalents and Short-Term Investments | 52.15B | 38.22B | 32.66B | 31.10B | 30.59B |
Total Debt | 1.23B | 1.32B | 1.14B | 1.12B | 834.37M |
Total Liabilities | 24.47B | 25.46B | 22.90B | 22.48B | 15.63B |
Stockholders Equity | 106.12B | 92.71B | 84.36B | 78.71B | 69.47B |
Cash Flow | |||||
Free Cash Flow | 17.00B | 10.13B | 7.37B | 4.70B | 7.33B |
Operating Cash Flow | 19.20B | 12.44B | 13.46B | 7.42B | 8.68B |
Investing Cash Flow | -3.59B | -1.12B | -6.71B | -4.69B | -3.91B |
Financing Cash Flow | -3.53B | -6.27B | -7.55B | -3.79B | -1.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | ¥152.80B | 11.43 | 14.24% | 2.93% | 1.52% | 8.45% | |
81 Outperform | ¥83.91B | 10.56 | 2.57% | 1.84% | 10.75% | ||
79 Outperform | ¥46.44B | 19.64 | 3.26% | 11.94% | 17.08% | ||
78 Outperform | ¥34.76B | 4.04 | 3.99% | 7.99% | 78.17% | ||
77 Outperform | ¥164.67B | 12.62 | 3.59% | 5.52% | -5.40% | ||
72 Outperform | ¥27.77B | 13.50 | 2.95% | 5.29% | 1.50% | ||
56 Neutral | £2.53B | 6.23 | -0.23% | 47.30% | 10.04% | 4.58% |